Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L04AA18
|
| gptkbp:brand |
gptkb:everolimus
|
| gptkbp:contraindication |
hypersensitivity to everolimus
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zortress
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:mechanismOfAction |
mTOR inhibitor
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
hypertension
infections hyperlipidemia delayed wound healing |
| gptkbp:usedFor |
prevention of organ rejection
|
| gptkbp:usedIn |
liver transplant
kidney transplant |
| gptkbp:bfsParent |
gptkb:everolimus
|
| gptkbp:bfsLayer |
6
|